Do You Have to Come In For Your Testosterone Injection?
What the NHS actually says about self-administration, equality, and your rights as a patient
A growing number of people on long-term testosterone injection therapy are being told by their GP practice that they must attend the surgery to have their injection administered by a nurse, and that refusing to do so could result in removal from the practice list. If this is happening to you, it is worth knowing what the NHS guidance actually says, because in many cases the policy being applied runs directly against it.
This guide answers the most common questions people have when they find themselves in this situation.
What does the NHS say about self-administration of medicines?
The NHS has a clear and published position on this. Patients should be supported to continue self-administering medicines they were already managing at home, and the starting assumption is that they are capable of doing so safely unless there is a specific, documented clinical reason to the contrary.
The traditional model, in which healthcare staff assumed responsibility for all medication administration the moment a patient was in any kind of clinical relationship, has been formally and explicitly challenged in NHS guidance. Increasingly, it is expected that if you were injecting your own medicine at home before any change in your care, you should continue to do so. This includes newly initiated medicines where clinically appropriate.
Any risk assessment that needs to take place begins from the presumption of competence, not from a blank slate, and certainly not from a presumption that clinical administration is required. Organisations accepting patients into their care also accept responsibility for managing the governance around self-administration safely, which means creating a proper framework for it rather than simply refusing it as a blanket policy.
Is testosterone injection specifically recognised as suitable for self-administration?
Yes. This is not an informal arrangement or a workaround. It is written into prescribing frameworks and clinical guidance across England. Sustanon 250, one of the most commonly prescribed intramuscular testosterone preparations, is documented as suitable for self-injection into the thigh, as opposed to administration by a healthcare professional into the buttock. Patients have been self-injecting testosterone for decades, and this is clinically well-established.
Regional prescribing committees across England publish testosterone prescribing frameworks for use in primary care. These frameworks are the documents that govern how your prescription is supposed to be managed between your specialist team and your GP. Many of them explicitly list self-injection into the thigh as a standard and recognised route of administration. The Hull and East Riding Prescribing Committee’s framework, to take one published example, states this clearly. Other regional frameworks reflect the same clinical consensus.
A GP practice policy that requires all testosterone injections to be administered at the surgery, without any individual clinical assessment, is not consistent with these frameworks. If your local framework recognises self-administration, a blanket clinic-only policy directly contradicts the document that is supposed to govern your care.
Can a GP practice just decide that everyone must come in for their injections?
A practice is entitled to set policies about how it organises and delivers care. What it cannot do is apply a blanket policy that overrides national NHS guidance, has no clinical justification for individual patients, or is applied in a way that treats some groups of patients differently from others without good clinical reason.
If you have been self-administering safely for a significant period, there is no clinical basis for an urgent enforced change to clinic administration. The practice would need to be able to point to a documented, patient-specific clinical reason why self-administration is no longer appropriate for you as an individual. A practice-wide administrative decision does not meet that standard, and it is entirely reasonable to ask the practice to explain the clinical evidence base for their position in relation to your specific circumstances.
It is also worth asking whether the policy applies equally to all patients on long-term testosterone therapy, whatever the reason for their prescription. If it does not, you will want to understand why.
Should cis and trans patients be treated in the same way?
Yes, and this is not simply a matter of good practice. It is a matter of equality law.
Testosterone is prescribed for a number of different clinical reasons, including male hypogonadism, gender-affirming hormone therapy, and other endocrine conditions. The medication, the injection technique, the monitoring requirements, and the clinical risks are the same regardless of why the prescription was issued. A practice policy that applies differently to patients depending on the clinical reason for their testosterone prescription is making a distinction that has no clinical basis.
For a trans patient, the reason for their testosterone prescription is inseparable from their gender identity. Gender reassignment is a protected characteristic under the Equality Act 2010. If a practice is routinely permitting cis male patients to self-administer their testosterone injections while requiring trans patients to attend the surgery for theirs, this is differential treatment on grounds that cannot be clinically justified, and it may constitute indirect discrimination under the Equality Act.
The NHS Equality, Diversity and Inclusion Improvement Plan, published by NHS England, explicitly identifies LGBT+ people as a group requiring active protection from discriminatory policies and inequitable treatment. NHS organisations are expected to review their data and policies for exactly this kind of disparity, and to address it.
If you are a trans patient and you believe the policy is being applied differently to you than it would be to a cis patient in the same clinical situation, it is worth raising this directly and in writing with the practice, and keeping a record of the response.
My practice is threatening to remove me from the list if I do not comply. Can they do that?
Removal from a GP practice list is supposed to be a rare event, used only as a genuine last resort. The BMA’s guidance on this is very clear, and the threshold is substantially higher than many practices acknowledge.
Before any removal proceedings can properly begin, the practice must issue a formal written warning to the patient, setting out clearly the reasons for the possibility of removal. That warning is valid for twelve months. Simply mentioning in a consultation that a letter might be sent is not the same as issuing a formal warning.
The practice should also consult an independent party, such as the secretary of the Local Medical Committee, before a removal decision is made. And crucially, the basis for removal must be an irretrievable breakdown in the doctor-patient relationship, not a clinical disagreement, not a complaint, and not a patient exercising their right to challenge a policy they believe to be unjustified.
The BMA explicitly states that it neither supports nor condones the removal of patients because they have made a complaint. A patient who writes a formal letter questioning a practice policy, requesting an individual clinical assessment, and asking for the clinical evidence base for a decision has not contributed to any kind of breakdown. They have engaged constructively through the appropriate channel.
The BMA’s guidance also makes clear that removal cannot be on grounds of a patient’s medical condition. Using the threat of removal to coerce compliance with a policy that has no individual clinical justification comes very close to that line, and possibly crosses it.
What if I have been self-administering for years without any problems?
This is highly relevant, and it should be taken seriously in any clinical risk assessment. A well-documented history of safe self-administration over many years is strong evidence that you are capable of continuing. It is not a reason for increased clinical oversight; it is evidence against the need for it.
NHS guidance on self-administration of medicines requires that any risk assessment take into account the individual’s history and circumstances. An assessment that does not engage with a long, complication-free self-administration history is not a thorough assessment and would be difficult to defend clinically.
If you have any clinical or professional background relevant to injection technique, this is also a material factor in assessing risk, and it is reasonable to include it in any written response to the practice.
What should I do next?
The most important step is to engage in writing rather than verbally. A formal letter creates a record of your position, your clinical history, and your request for an individual assessment. It also makes clear that you are aware of your rights and of the relevant guidance.
There is a letter template accompanying this guide that you can adapt for your own situation. In your letter you should:
Set out your history of safe self-administration, including how long you have been self-injecting and that you have had no complications;
Ask the practice to conduct an individual clinical risk assessment specific to you, rather than applying a blanket policy;
Reference the relevant NHS guidance on self-administration and, where applicable, your local testosterone prescribing framework;
Ask the practice to confirm in writing whether the same policy applies to all patients on long-term testosterone therapy, regardless of the clinical indication;
If you are a trans patient, note the Equality Act 2010 protected characteristic of gender reassignment and ask for the basis on which any differential treatment is justified;
Ask for a written response within 14 days.
If the practice does not respond satisfactorily, you can escalate to your Local Medical Committee, your Integrated Care Board, or NHS England. You can also raise a formal complaint under the NHS complaints procedure. If you believe there is a discrimination issue, the Equality Advisory and Support Service can provide guidance.
You are not causing trouble by doing any of this. You are doing exactly what the NHS expects patients to do.
What does a genuine breakdown in the doctor-patient relationship actually look like?
This is worth understanding clearly, because the phrase is sometimes used in a way that is broader than the BMA’s guidance allows. A genuine, irretrievable breakdown that would justify removal from a practice list typically involves persistent abusive or threatening behaviour towards practice staff, circumstances that make it genuinely clinically impossible to provide appropriate care, or a level of mistrust so profound on both sides that no functional clinical relationship can be maintained.
A patient who attends their appointments, takes their medication as prescribed, engages with their clinical team, and challenges a policy through formal written correspondence has not contributed to any breakdown in their clinical relationship. Robust advocacy for your own autonomy in managing a medicine you have used safely for years is not a relationship breakdown. It is good self-care, and the NHS should support it.
References
NHS England / Royal Pharmaceutical Society. Implementing self-administration of medicines.
Hull and East Riding Prescribing Committee. Prescribing Framework for Testosterone in Adults.
NHS England. NHS Equality, Diversity and Inclusion Improvement Plan. Published 2023.
Equality Act 2010. Gender reassignment as a protected characteristic. Section 7.
NHS England. Responsibility for prescribing between primary and secondary/tertiary care. March 2018.
British Society for Sexual Medicine. BSSM Guidelines on Adult Testosterone Deficiency.
Dr Helen Webberley, Gender Specialist and Medical Educator
I have never had a hormone injection ! I have pils which I take by dissolving them under my tongue
Before my surgery it was 2 a day but now just one at night . They are oestrogen Valerate. Is there something similar a Trans Man could take for Testosterone. This would settle the injection debate. Or would it ?
I, a cis man, old cis man, tried Therapy for a while to see if it would improve my quality of life. Turned out I needed to exercise and work on my depression with alternative solutions. Anyway, I went private obviously as HRT is not available for men, and after having bloods done etc started. I was given my needles etc and a video link. It wasn't hard.